A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors Meeting Abstract
| Authors: | Juric, D.; Rodon, J.; Bauer, T. M.; Wainberg, Z.; Tolaney, S.; Modi, S.; Martin, A. G.; Hengelage, T.; Melendez, M.; Choudhury, S.; Nauwelaerts, H.; Bedard, P. L. |
| Abstract Title: | A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S68 |
| Language: | English |
| ACCESSION: | WOS:000361887400211 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)30205-2 |
| Notes: | Meeting Abstract: 342 -- Source: Wos |
